Meningitis News and Research

Latest Meningitis News and Research

Resveratrol worsens MS-like neuropathology and inflammation, study finds

Resveratrol, a naturally occurring polyphenol compound produced by the skin of red grapes and peanuts, and found in red wine, has been touted as a beneficial supplement due to its anti-inflammatory and antioxidant properties.

1 Oct 2013

Patients treated by ID physicians less likely to die in hospital

In a first-of-its-kind study to evaluate the impact of a medical specialty on patient outcomes, researchers found that hospitalized patients with severe infections such as meningitis and Clostridium difficile are significantly less likely to die if they receive care from an infectious diseases specialist. The study, which analyzed nearly 130,000 Medicare patient cases, is now available online and will be published in the December 15 issue of Clinical Infectious Diseases.

30 Sep 2013

FDA expands Hizentra administration options for people with primary immunodeficiency

CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.

28 Sep 2013

University of Maryland receives renewed NIH funding for vaccine research

The University of Maryland School of Medicine's Center for Vaccine Development (CVD) has successfully competed for and received a renewed contract to conduct basic research and clinical studies of vaccines, diagnostics, and therapeutics. Support for this work to combat existing and emerging infectious diseases is provided by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

27 Sep 2013

House and Senate negotiators reaching agreement on compounding pharmacy legislation

The measure would apply uniform national standards to pharmacy compounding while enacting a track-and-trace system to ensure the safety of drugs throughout the supply chain.

27 Sep 2013

Lawmakers weigh deal giving FDA reater clout after meningitis outbreak

House and Senate negotiators appear to be making progress towards stiffer regulations over the type of drugs that caused last year's outbreak. In other Capitol Hill news, the GOP pushes to repeal a tax on medical devices, and rural health care providers ask for more time to meet electronic health record deadlines.

26 Sep 2013

Battle brewing over new regulations for compounding pharmacies

In addition, a bill that would require professional drivers to be tested for sleep apnea flies through the House.

25 Sep 2013

First Edition: September 24, 2013

Today's headlines include reports about Senate action on the effort to defund the health law as well as a scheduled appearance by former President Bill Clinton and President Barack Obama to kick off the roll out of a key part of the overhaul.

24 Sep 2013

State highlights: Penn State ends health plan penalty

After weeks of vociferous objections by faculty members, Pennsylvania State University said on Wednesday it was suspending part of a new employee wellness program that some professors had criticized as coercive and financially punitive (Singer, 9/18).

20 Sep 2013

Research: Steroids in spinal shots may not provide relief from lower back pain

New research from Johns Hopkins suggests that it may not be the steroids in spinal shots that provide relief from lower back pain, but the mere introduction of any of a number of fluids, such as anesthetics and saline, to the space around the spinal cord.

18 Sep 2013

Study evaluates effectiveness of new meningitis serogroup A vaccine in sub-Saharan Africa

Evaluation of the effectiveness of a mass vaccination campaign with a new meningitis serogroup A vaccine, PsA-TT, in sub-Saharan Africa found that it had a dramatic impact on cases of serogroup meningitis and on carriage of the disease-causing bacteria in the throat, according to new research published in The Lancet.

13 Sep 2013

MenAfriVac reduces incidence of meningitis by 94%

A new meningitis vaccine (MenAfriVac) is highly effective at protecting against epidemic A meningococcal disease, common in Africa’s meningitis belt where it accounts for at least three quarters of cases, and against transmission of the bacterium that causes these epidemics, according to new research published in The Lancet.

13 Sep 2013

House to consider measure to hold Obamacare exchange subsidies until applicants' income is verified

In other news on Capitol Hill: Sen. McConnell's close ties to Humana are examined, the Senate eyes legislation giving the Food and Drug Administration greater oversight of compounding pharmacies, and Republican lawmakers are questioning Obamacare's hiring practices.

11 Sep 2013

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet Pharmaceuticals, Inc. announced today the initiation of the phase 2 clinical program for its antifungal agent VT-1161. The initial phase 2 study is designed to evaluate the safety and efficacy of VT-1161 in the treatment of vulvovaginal candidiasis (VVC) and is being conducted at leading clinical centers in the United States.

7 Sep 2013

HIV-infected people who carry gene face greater risk of contracting cryptococcal disease

HIV-infected people who carry a gene for a specific protein face a 20-fold greater risk of contracting cryptococcal disease, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.

27 Aug 2013

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

The U.S. Food and Drug Administration today allowed marketing in the U.S. of the first mass spectrometer system for automated identification of bacteria and yeasts that are known to cause serious illness in humans.

22 Aug 2013

U.S. probes whether Medicaid programs prescribe antipsychotics to children too often

Health officials are investigating whether health care professionals are prescribing antipsychotic drugs too often to children on Medicaid. In the meantime, a Texas compounding pharmacy has become the latest to have its products recalled over meningitis concerns.

13 Aug 2013

Researchers create an efficient technique to target and repair defective genes

Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers from the Morgridge Institute for Research and Northwestern University have created an efficient way to target and repair defective genes.

13 Aug 2013

First Edition: Aug. 12, 2013

Today's headlines include reports about state action on the health law's implementation and other news from the health insurance marketplace.

12 Aug 2013

SGR repeal measure moves to full House consideration

Some medical societies, which support repealing Medicare's Sustainable Growth Rate formula, are expressing concern that a bill won't be signed into law before a scheduled 25 percent reduction in Medicare physician payment takes effect. Meanwhile, members of the Senate Finance Committee are working on their own plan.

2 Aug 2013

Meningitis News and Research

Latest Meningitis News and Research

Resveratrol worsens MS-like neuropathology and inflammation, study finds

Patients treated by ID physicians less likely to die in hospital

FDA expands Hizentra administration options for people with primary immunodeficiency

University of Maryland receives renewed NIH funding for vaccine research

House and Senate negotiators reaching agreement on compounding pharmacy legislation

Lawmakers weigh deal giving FDA reater clout after meningitis outbreak

Battle brewing over new regulations for compounding pharmacies

First Edition: September 24, 2013

State highlights: Penn State ends health plan penalty

Research: Steroids in spinal shots may not provide relief from lower back pain

Study evaluates effectiveness of new meningitis serogroup A vaccine in sub-Saharan Africa

MenAfriVac reduces incidence of meningitis by 94%

House to consider measure to hold Obamacare exchange subsidies until applicants' income is verified

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

HIV-infected people who carry gene face greater risk of contracting cryptococcal disease

FDA approves first mass spectrometer system in U.S. for identification of bacteria, yeasts

U.S. probes whether Medicaid programs prescribe antipsychotics to children too often

Researchers create an efficient technique to target and repair defective genes

First Edition: Aug. 12, 2013

SGR repeal measure moves to full House consideration

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Meningitis News and Research

Latest Meningitis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in